Sickle Cell Disease Treatment Global Market Report 2024

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	175 Pages	The Business Research Company	January, 2024	BRC18450643

Best Price Guarantee
Price	from $5,000
Length	175 Pages
Publisher	The Business Research Company
Published Date	January, 2024
SKU	BRC18450643

Sickle Cell Disease Treatment Global Market Report 2024

Including: 1) By Treatment Modality: Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant2) By Disease Type: Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC)3) By Route Of Administration: Oral; Parenteral4) By End-User: Hospitals; Specialty ClinicsCovering: Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; Johnson & Johnson Private Limited; Merck & Co Inc.; Novartis AG

Sickle Cell Disease Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sickle cell disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for sickle cell disease treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sickle cell disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Treatment Modality: Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types

3) By Route Of Administration: Oral; Parenteral

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Companies Mentioned: Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; Johnson & Johnson Private Limited; Merck & Co Inc.; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Sickle Cell Disease Treatment Market Characteristics
3. Sickle Cell Disease Treatment Market Trends And Strategies
4. Sickle Cell Disease Treatment Market - Macro Economic Scenario: 4.1. Impact Of High Inflation On The Market; 4.2. Ukraine-Russia War Impact On The Market; 4.3. COVID-19 Impact On The Market
5. Global Sickle Cell Disease Treatment Market Size and Growth: 5.1. Global Sickle Cell Disease Treatment Market Drivers and Restraints; 5.1.1. Drivers Of The Market; 5.1.2. Restraints Of The Market; 5.2. Global Sickle Cell Disease Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion); 5.3. Global Sickle Cell Disease Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Sickle Cell Disease Treatment Market Segmentation: 6.1. Global Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant; 6.2. Global Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types; 6.3. Global Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Oral; Parenteral; 6.4. Global Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; Hospitals; Specialty Clinics; Other End-Users
7. Sickle Cell Disease Treatment Market Regional And Country Analysis: 7.1. Global Sickle Cell Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 7.2. Global Sickle Cell Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Sickle Cell Disease Treatment Market: 8.1. Asia-Pacific Sickle Cell Disease Treatment Market Overview; Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.3. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 8.4. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Sickle Cell Disease Treatment Market: 9.1. China Sickle Cell Disease Treatment Market Overview; 9.2. China Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.3. China Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion; 9.4. China Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Sickle Cell Disease Treatment Market: 10.1. India Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.2. India Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 10.3. India Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Sickle Cell Disease Treatment Market: 11.1. Japan Sickle Cell Disease Treatment Market Overview; 11.2. Japan Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.3. Japan Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 11.4. Japan Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Sickle Cell Disease Treatment Market: 12.1. Australia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.2. Australia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 12.3. Australia Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Sickle Cell Disease Treatment Market: 13.1. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.2. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 13.3. Indonesia Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Sickle Cell Disease Treatment Market: 14.1. South Korea Sickle Cell Disease Treatment Market Overview; 14.2. South Korea Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.3. South Korea Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 14.4. South Korea Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Sickle Cell Disease Treatment Market: 15.1. Western Europe Sickle Cell Disease Treatment Market Overview; 15.2. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.3. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 15.4. Western Europe Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Sickle Cell Disease Treatment Market: 16.1. UK Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.2. UK Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 16.3. UK Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Sickle Cell Disease Treatment Market: 17.1. Germany Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.2. Germany Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 17.3. Germany Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Sickle Cell Disease Treatment Market: 18.1. France Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.2. France Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 18.3. France Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Sickle Cell Disease Treatment Market: 19.1. Italy Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.2. Italy Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 19.3. Italy Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Sickle Cell Disease Treatment Market: 20.1. Spain Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.2. Spain Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 20.3. Spain Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Sickle Cell Disease Treatment Market: 21.1. Eastern Europe Sickle Cell Disease Treatment Market Overview; 21.2. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.3. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 21.4. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Sickle Cell Disease Treatment Market: 22.1. Russia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.2. Russia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 22.3. Russia Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Sickle Cell Disease Treatment Market: 23.1. North America Sickle Cell Disease Treatment Market Overview; 23.2. North America Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.3. North America Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 23.4. North America Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Sickle Cell Disease Treatment Market: 24.1. USA Sickle Cell Disease Treatment Market Overview; 24.2. USA Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.3. USA Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 24.4. USA Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Sickle Cell Disease Treatment Market: 25.1. Canada Sickle Cell Disease Treatment Market Overview; 25.2. Canada Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.3. Canada Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 25.4. Canada Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Sickle Cell Disease Treatment Market: 26.1. South America Sickle Cell Disease Treatment Market Overview; 26.2. South America Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.3. South America Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 26.4. South America Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Sickle Cell Disease Treatment Market: 27.1. Brazil Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.2. Brazil Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 27.3. Brazil Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Sickle Cell Disease Treatment Market: 28.1. Middle East Sickle Cell Disease Treatment Market Overview; 28.2. Middle East Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.3. Middle East Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 28.4. Middle East Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Sickle Cell Disease Treatment Market: 29.1. Africa Sickle Cell Disease Treatment Market Overview; 29.2. Africa Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.3. Africa Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion; 29.4. Africa Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Sickle Cell Disease Treatment Market Competitive Landscape And Company Profiles: 30.1. Sickle Cell Disease Treatment Market Competitive Landscape; 30.2. Sickle Cell Disease Treatment Market Company Profiles; 30.2.1. Sun Pharmaceutical Industries Ltd.; 30.2.1.1. Overview; 30.2.1.2. Products and Services; 30.2.1.3. Strategy; 30.2.1.4. Financial Performance; 30.2.2. Pfizer Inc.; 30.2.2.1. Overview; 30.2.2.2. Products and Services; 30.2.2.3. Strategy; 30.2.2.4. Financial Performance; 30.2.3. Johnson & Johnson Private Limited; 30.2.3.1. Overview; 30.2.3.2. Products and Services; 30.2.3.3. Strategy; 30.2.3.4. Financial Performance; 30.2.4. Merck & Co Inc.; 30.2.4.1. Overview; 30.2.4.2. Products and Services; 30.2.4.3. Strategy; 30.2.4.4. Financial Performance; 30.2.5. Novartis AG; 30.2.5.1. Overview; 30.2.5.2. Products and Services; 30.2.5.3. Strategy; 30.2.5.4. Financial Performance
31. Sickle Cell Disease Treatment Market Other Major And Innovative Companies: 31.1. Sanofi S.A.; 31.2. Bristol-Myers Squibb Company; 31.3. AstraZeneca plc; 31.4. Eli Lilly and Company; 31.5. Gilead Sciences Inc.; 31.6. Amgen Inc.; 31.7. Baxter International Inc.; 31.8. Teva Pharmaceutical Industries Ltd.; 31.9. Vertex Pharmaceuticals Incorporated; 31.10. Alnylam Pharmaceuticals Inc.; 31.11. Ionis Pharmaceuticals Inc.; 31.12. Silver Lake Research Corporation0.45; 31.13. Global Blood Therapeutics Inc.; 31.14. Acceleron Pharma Inc.; 31.15. Sangamo Therapeutics Inc.
32. Global Sickle Cell Disease Treatment Market Competitive Benchmarking
33. Global Sickle Cell Disease Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Sickle Cell Disease Treatment Market
35. Sickle Cell Disease Treatment Market Future Outlook and Potential Analysis: 35.1 Sickle Cell Disease Treatment Market In 2028 - Countries Offering Most New Opportunities; 35.2 Sickle Cell Disease Treatment Market In 2028 - Segments Offering Most New Opportunities; 35.3 Sickle Cell Disease Treatment Market In 2028 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer